Concepedia
Statistics
Publications
4
Citations
3.5K
H-Index
Active since
2019
Affiliations
Universidad de Guadalajara(Current)
University of Toronto
Polish Academy of Sciences
University of Cape Town
McMaster University
Anastasia Gorbunova is an author at Universidad de Guadalajara specializing in medicine, diabetes, and metabolic syndrome.
Top concepts
MedicineDiabetesMetabolic SyndromeUrologyPathologyCell DeathImmunologyNephrologyPharmacologyHealth Policy
Publications per year
2019–2022
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text
Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text
Metabolic Syndrome, Diabetes Management, Urology +10
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-Cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
Ali H. Zaidi, Ronan J. Kelly, Anastasia Gorbunova et al. · Oncotarget · 2021 · 38 citations · Full text
CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model
Ashten N. Omstead, Michael Paskewicz, Anastasia Gorbunova et al. · Carcinogenesis · 2022 · 31 citations
Immunology, Cell Death, Pathology +18
1–4 of 4